Categories: News

TrialCard Announces ISO 27001 Certification

MORRISVILLE, N.C., April 2, 2019 /PRNewswire/ — TrialCard Incorporated, a leader in access, affordability, adherence, and engagement solutions for patients and healthcare providers, today announced that it has received ISO 27001:2013 certification for its Information Security Management System (ISMS).

ISO 27001:2013 is an ISMS standard published in October 2013 by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC).

A-lign, an independent, third-party auditor, found TrialCard to have technical controls in place and formalized IT Security policies and procedures.  A-lign is an ISO/IEC 27001 certification body accredited by the ANSI-ASQ National Accreditation Board (ANAB) to perform ISO 27001 certifications.  TrialCard has implemented several security measures and countermeasures that protect it from unauthorized access or compromise and IT personnel were found to be conscientious and knowledgeable in best practices.

Compliance with this internationally recognized standard confirms that TrialCard’s security management program is comprehensive and follows leading practices.  This certification demonstrates TrialCard’s continued commitment to information security at every level and ensures that data security has been addressed, implemented and properly controlled in all areas of the organization.

“TrialCard has invested three years into pursuing ISO 27001 certification.  Data security has been a company-wide endeavor and a key priority for us,” said Stan Kurpiel, Chief Information Officer for TrialCard.  “Companies that partner with TrialCard can be confident that we have done everything in our power to protect client and patient data within our environment.”

“Due to the sheer number of data security and privacy breaches that occur in today’s society, we felt like we owed it to our clients to provide the best data security protocols possible,” said Mark Bouck, TrialCard’s President and CEO.  “ISO 27001 certification is the gold standard in a vitally important area of our business.  This is a significant accomplishment for our company and truly sets us apart from our competitors in the area of data security and privacy.”

For more information about TrialCard’s ISO 27001 certification and its commitment to data security and privacy, visit its online Resources library.

About TrialCard

TrialCard Incorporated provides patient affordability, medication access and adherence, patient support, and clinical trial supply management services on behalf of pharmaceutical manufacturers. Founded in 2000, TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date.  The company is headquartered in Morrisville, North Carolina. For more information, please visit www.trialcard.com.

Contact:                                                                                                   
Michael Carlin
Vice President, Marketing
TrialCard Incorporated
mcarlin@trialcard.com
919-415-3105

View original content:http://www.prnewswire.com/news-releases/trialcard-announces-iso-27001-certification-300822280.html

SOURCE TrialCard

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

1 hour ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

1 hour ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

1 hour ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

1 hour ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

1 hour ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

2 hours ago